Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus

Journal of Cellular Biochemistry

Volumn 114, Issue 3, 2013, Pages 525-531

  Akash, Muhammad Sajid Hamid ^a,b   Rehman, Kanwal ^a   Chen, Shuqing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

DYSLIPIDEMIA; HYPERGLYCEMIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST; OXIDATIVE STRESS; PRO INFLAMMATORY CYTOKINES

Indexed keywords

ADENOSINE TRIPHOSPHATE; C REACTIVE PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

CELL DEATH; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; GENE INDUCTION; HYPOXIA; IMMUNOPATHOGENESIS; INFLAMMATION; MACROPHAGE; MEDIATOR RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERNUTRITION; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

APOPTOSIS; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; OXIDATIVE STRESS;

EID: 84872772714     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24402     Document Type: Review

References (63)

1. Akash MSH, Rehman K, Rasool F, Sethi A, Abrar MA, Irshad A, Abid A, Murtaza G,. 2011. Alternate therapy of type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae). J Med Plants Res 5: 6885-6889.
2. Akash MSH, Shen Q, Rehman K, Chen S,. 2012a. Interleukin-1 receptor antagonist: A new therapy for type 2 diabetes mellitus. J Pharm Sci 101: 1647-1658.
3. Akash MSH, Rehman K, Li N, Gao JQ, Sun H, Chen S,. 2012b. Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. Pharm Res DOI: 10.1007/s11095-012-0843-0.
4. Arafat HA, Katakam AK, Chipitsyna G, Gong Q, Vancha AR, Gabbeta J, Dafoe DC,. 2007. Osteopontin protects the islets and β-cells from interleukin-1 β-mediated cytotoxicity through negative feedback regulation of nitric oxide. Endocrinology 148: 575-584.
5. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M,. 2005. IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198.
6. Böni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, Kerr-Conte J, Pattou F, Halban PA, Weir GC, Donath MY,. 2008. Increased interleukin (IL)-1betamessenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93: 4065-4074.
7. Boni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier DT, Prazak R, Kerr-Conte J, Pattou F, Ehses JA, Schuit FC, Donath MY,. 2009. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150: 5218-5229.
8. Brooks-Worrell BM, Reichow JL, Goel A, Ismail H, Palmer JP,. 2011. Identification of autoantibody-negative autoimmune type 2 diabetic patients. Diabetes Care 34: 168-173.
9. Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L, Lewis CE,. 2003. Hypoxia-induced gene expression in human macrophages: Implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 163: 1233-1243.
10. Carmeliet P,. 2005. Angiogenesis in life, disease and medicine. Nature 438: 932-936.
11. Cnop M, Igoillo-Esteve M, Cunha DA, Ladriere L, Eizirik DL,. 2008. An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells. Biochem Soc Trans 36: 909-915.
12. Dedon PC, Tannenbaum SR,. 2004. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423: 12-22.
13. Dinarello CA,. 2010. Anti-inflammatory agents: Present and future. Cell 140: 935-950.
14. Dinarello CA,. 2011. Blocking interleukin-1β in acute and chronic autoinflammaotry diseases. J Intern Med 269: 16-28.
15. Donath MY, Shoelson SE,. 2011. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107.
16. Donath MY, Gross DJ, Cerasi E, Kaiser N,. 1999. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48: 738-744.
17. Donath MY, Ellingsgaard H, Schumann DM, Perren A, Faulenbach M, Ehses JA,. 2008. Islet inflammation in type 2 diabetes: From metabolic stress to therapy. Diabetes Care 31: S161-S164.
18. Donath MY, Boni-Schnetzler M, Ellingsgaard H, Ehses JA,. 2009. Islet inflammation impairs the pancreatic β-cell in type 2 diabetes. Physiology 24: 325-331.
19. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MK, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F, Donath MY,. 2007. Increased number of islet associated macrophages in type 2 diabetes. Diabetes 56: 2356-2370.
20. Ehses JA, Ellingsgaard H, Boni-Schnetzler M, Donath MY,. 2009a. Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction. Arch Physiol Biochem 115: 240-247.
21. Ehses JA, Lacraz G, Giroix M, Schmidlin F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B, Homo-Delarche F, Donath MY,. 2009b. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA 106: 13998-14003.
22. Ehses JA, Meier DT, Wueest S, Rytka J, Boller S, Wielinga PY, Schraenen A, Lemaire K, Debray S, Van Lommel L, Pospisilik JA, Tschopp O, Schultze SM, Malipiero U, Esterbauer H, Ellingsgaard H, Rutti S, Schuit FC, Lutz TA, Boni-Schnetzler M, Konrad D, Donath MY,. 2010. Toll-like receptor 2-deficient mice are protected from insulin resistance and β cell dysfunction induced by a high-fat diet. Diabetologia 53: 1795-1806.
23. Eizirik DL, Cardozo AK, Cnop M,. 2008. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29: 42-61.
24. Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, Klein T, Serup P, Eizirik DL, melloul D,. 2006. Conditional and specific NF-κB blockade protects pancreatic β cells from diabetogenic agents. Proc Natl Acad Sci USA 103: 5072-5077.
25. Evans JL, Goldfine ID, Maddux BA, Grodsky GM,. 2002. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622.
26. Evans JL, Goldfine ID, Maddux BA, Grodsky GM,. 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction ? Diabetes 52: 1-8.
27. Fève B, Bastard JP,. 2009. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 5: 305-311.
28. Goldfine AB, Fonseca V, Shoelson SE,. 2011. Therapeutic approaches to target inflammation in type 2 diabetes. Clin Chem 57: 162-167.
29. Hayden MR, Sowers JR,. 2007. Isletopathy in Type 2 diabetes mellitus: Implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress. Antioxid Redox Signal 9: 891-910.
30. Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabak AG, Schloot DR,. 2009. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: The Whitehall II study. Diabetes Care 32: 421-423.
31. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I,. 2007. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56: 901-911.
32. Hotamisligil GS, Erbay E,. 2008. Nutrient sensing and inflammation in metabolic diseases. Nature Rev Immunol 8: 923-934.
33. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa S, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M,. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-1505.
34. Lambert AJ, Brand MD,. 2004. Inhibitors of the quinone binding site allow rapid superoxide production from mitochondrial NADH: Ubiquinone oxidoreductase (complex I). J Biol Chem 279: 39414-39420.
35. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY,. 2002. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110: 851-860.
36. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY,. 2003. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52: 726-733.
37. Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA, Donath MY,. 2004. Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci USA 101: 8138-8143.
38. Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Go'mez-Reino JJ, Gualillo O,. 2005. Leptin, from fat to inflammation: Old questions and new insights. FEBS Lett 579: 295-301.
39. Pasarica M, Rood J, Ravussin E, Schwarz JM, Smith SR, Redman LM,. 2010. Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis. J Clin Endocrinol Metab 95: 4052-4055.
40. Poitout V, Robertson RP,. 2002. Minireview: Secondary beta-cell failure in type 2 diabetes-A convergence of glucotoxicity and lipotoxicity. Endocrinology 143: 339-342.
41. Poitout V, Robertson RP,. 2008. Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr Rev 29: 351-366.
42. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM,. 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334.
43. Prasad SK, Kulshreshtha A, Qureshi TN,. 2009. Antidiabetic activity of some herbal plants in streptozotocin induced diabetic albino rats. Pak J Nutr 8: 551-557.
44. Prentki M, Nolan CJ,. 2006. Islet β cell failure in type 2 diabetes. J Clin Invest 116: 1802-1812.
45. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD,. 1988. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024.
46. Robertson RP, Harmon J, Tran PO, Poitout V,. 2004. β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53: S119-S124.
47. Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S, Bideau M, Capponi A, Nicod P, Haefliger JA, Waeber G,. 2003. Insulin-secreting β-cell dysfunction induced by human lipoproteins. J Biol Chem 278: 18368-18375.
48. Rosenvinge A, Krogh-Madsen R, Baslund B, Pedersen BK,. 2007. Insulin resistance in patients with rheumatoid arthritis: Effect of anti-TNFα therapy. Scand J Rheumatol 36: 91-96.
49. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ,. 2008. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322: 1539-1543.
50. Shanmugam N, Reddy MA, Guha M, Natarajan R,. 2003. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52: 1256-1264.
51. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS,. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025.
52. Shoelson SE, Lee J, Goldfine AB,. 2006. Inflammation and insulin resistance. J Clin Invest 116: 1793-1801.
53. Solinas G, Karin M,. 2010. JNK1 and IKKβ: Molecular links between obesity and metabolic dysfunction. FASEB J 24: 2596-2611.
54. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF,. 2003. Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European prospective investigation into cancer and nutrition (EPIC)-potsdam study. Diabetes 52: 812-817.
55. Tilg H, Moschen AR,. 2008. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14: 222-231.
56. Tu BP, Weissman JS,. 2004. Oxidative protein folding in eukaryotes: Mechanisms and consequences. J Cell Biol. 164: 341-346.
57. van Raalte DH, Diamant M,. 2011. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: Target for durable therapy ? Diab Res Clin Pract 93: S37-S46.
58. Weir GC, Bonner-Weir S,. 2004. Five stages of evolving β-cell dysfunction during progression to diabetes. Diabetes 53: S16-S21.
59. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H,. 2004. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323: 630-635.
60. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J,. 2010a. Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090-1101.
61. Yang J, Chi Y, Burkhardt BR, Guan Y, Wolf BA,. 2010b. Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr Rev 68: 270-279.
62. Yin J, Gao Z, He Q, Zhou D, Guo Z, Ye J,. 2009. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296: E333-E342.
63. Zhao YF, Feng DD, Chen C,. 2006. Contribution of adipocyte-derived factors to β-cell dysfunction in diabetes. Int J Biochem Cell Biol 38: 804-819.